MedTrace Logo

Treatment of Androgenic Alopecia in Males

NCT00947219 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2013-01-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks compared to baseline measurements.

Conditions

Interventions

DEVICE

HairMax LaserComb

Device application 3 times week (non-consecutive days), for 26 weeks

DEVICE

Control device

Device is used 3 times a week on non-consecutive days

Sponsors & Collaborators

  • Lexington International, LLC

    lead INDUSTRY

Principal Investigators

  • Zoe Draelos, MD · High Point, NC

  • David Goldberg, M.D. · Skin & Laser

  • Abe Marcadis, M.D. · Palm Beach Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00947219 on ClinicalTrials.gov